EUVIMEDEUVIMED entdecken
Crossref

Realizing the Promise of Tumor Infiltrating Lymphocytes as a New Biomarker for Personalized Medicine May Require the Power and Precision of Artificial Intelligence

Michael C. Montalto

AI in Precision Oncology · 2024

DOI: 10.1089/aipo.2023.0003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AI in Precision Oncology, 2024. Verfasst von Michael C. Montalto. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Montalto, M. C. (2024). Realizing the Promise of Tumor Infiltrating Lymphocytes as a New Biomarker for Personalized Medicine May Require the Power and Precision of Artificial Intelligence. AI in Precision Oncology. https://doi.org/10.1089/aipo.2023.0003

Vancouver

Montalto MC. Realizing the Promise of Tumor Infiltrating Lymphocytes as a New Biomarker for Personalized Medicine May Require the Power and Precision of Artificial Intelligence. AI in Precision Oncology. 2024. doi:10.1089/aipo.2023.0003

BibTeX
@article{Montalto2024,
  author = {Montalto, Michael C.},
  title = {Realizing the Promise of Tumor Infiltrating Lymphocytes as a New Biomarker for Personalized Medicine May Require the Power and Precision of Artificial Intelligence},
  journal = {AI in Precision Oncology},
  year = {2024},
  doi = {10.1089/aipo.2023.0003}
}
Kostenlos starten →